Rheumatoid arthritis in England 1996 to 2004. Mortality trends



Similar documents
THE AUSTRALIAN MESOTHELIOMA REGISTRY (AMR)

Chapter 15 Multiple myeloma

Figure 1.1 Percentage of persons without health insurance coverage: all ages, United States,


Chapter 2: Health in Wales and the United Kingdom

Indicator 7: Mortality

Cancer Incidence and Survival By Major Ethnic Group, England,

Prostate cancer statistics

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2008 MORTALITY 1997 TO 2007

bulletin 126 Healthy life expectancy in Australia: patterns and trends 1998 to 2012 Summary Bulletin 126 NOVEMBER 2014

Fewer people with coronary heart disease are being diagnosed as compared to the expected figures.

MESOTHELIOMA IN AUSTRALIA INCIDENCE 1982 TO 2009 MORTALITY 1997 TO 2011

Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore National Registry of Diseases Office (NRDO)

How To Track Life Expectancy In England

Patient survey report Category C Ambulance Service User Survey 2008 North East Ambulance Service NHS Trust

Big Data for Population Health and Personalised Medicine through EMR Linkages

The rate of hospitalizations due to assaultive injuries by spouse or partner (E976.3) per 100,000 females (13 and over)

Mortality from Prostate Cancer Urological Cancers SSCRG

Number. Source: Vital Records, M CDPH

Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD

Mesothelioma in Australia: Incidence (1982 to 2013) and Mortality (1997 to 2012)

New Zealand mortality statistics: 1950 to 2010

Finnish Cancer Registry Institute for Statistical and Epidemiological Cancer Research. Survival ratios of cancer patients by area in Finland

AP Statistics. Chapter 4 Review

Cancer in Ireland 2013: Annual report of the National Cancer Registry

Analysis of Population Cancer Risk Factors in National Information System SVOD

Outcomes benchmarking support packs: LA level

Scottish Diabetes Survey Scottish Diabetes Survey Monitoring Group

Prostate Cancer in the West Midlands

JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President

NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN)

HSCIC Statistical Publications

How To Analyse The Causes Of Injury In A Health Care System

REFERENCE CODE GDHCER PUBLICAT ION DATE JULY 2015 MULTIPLE MYELOMA EPIDEMIOLOGY FORECAST TO 2023

Table 1. Underlying causes of death related to alcohol consumption, International Classification of Diseases, Ninth Revision

Deaths from Respiratory Diseases: Implications for end of life care in England. June

Wisconsin Health Trends: 2011 Progress Report

The American Cancer Society Cancer Prevention Study I: 12-Year Followup

Ambulatory Care Sensitive Emergency Department Visits Chronic Disease Conditions New Hampshire, Background:

Births and deaths in Kent

Globally 12% of all deaths among adults aged 30 years and over were attributed to tobacco.

Beyond 2011: Population Coverage Survey Field Test 2013 December 2013

This profile provides statistics on resident life expectancy (LE) data for Lambeth.

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

inflammation of the pancreas and damage to the an increased risk of hypertension, stroke and Table 7.1: Classification of alcohol consumption

9. Substance Abuse. pg : Self-reported alcohol consumption. pg : Childhood experience of living with someone who used drugs

Summary Measures (Ratio, Proportion, Rate) Marie Diener-West, PhD Johns Hopkins University

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden

Informatics: Opportunities & Applications. Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit

Trends in life expectancy by the National Statistics Socio-economic Classification

2. Local Data to reduce Alcohol Related Harm and Comparison Groups

Albumin and All-Cause Mortality Risk in Insurance Applicants

Does smoking impact your mortality?

Key Health Areas Mapped to Out of Hospital Programme Areas

1.14 Life expectancy at birth

General Method: Difference of Means. 3. Calculate df: either Welch-Satterthwaite formula or simpler df = min(n 1, n 2 ) 1.

Actuarial projections for mesothelioma: an epidemiological perspective Mark Clements, Geoffrey Berry and Jill Shi

An Application of the G-formula to Asbestos and Lung Cancer. Stephen R. Cole. Epidemiology, UNC Chapel Hill. Slides:

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

A secondary analysis of primary care survey data to explore differences in response by ethnicity.

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for

Lung Cancer in the West Midlands

Pricing the Critical Illness Risk: The Continuous Challenge.


Non-response bias in a lifestyle survey

Measures of Prognosis. Sukon Kanchanaraksa, PhD Johns Hopkins University

Transcription:

Rheumatoid arthritis in England 1996 to 2004. Mortality trends Authors: Michael Goldacre, Marie Duncan, Paula Cook-Mozaffari, Matthew Davidson, Henry McGuiness, Daniel Meddings Published by: Unit of Health-Care Epidemiology, Oxford University, and South-East England Public Health Observatory, 2006 This document provides a profile of trends in mortality for rheumatoid arthritis in England. The period covered is January 1 1996 to December 31 2004. The data are analysed from mortality files supplied to the South East England Public Health Observatories (SEPHO) by the Office for National Statistics (ONS). Mortality rates were calculated for the condition certified as the underlying cause of death and for the disease certified as any mention on the death certificates. Age-specific mortality rates in 5-year age-groups were used to calculate age-standardised mortality rates with 95% confidence intervals for each time period. Age-truncated rates, with age-standardisation within them, are presented. We calculated the average annual percentage change from 1996-2004 in mortality rates for mentions, using data for each individual calendar year, by fitting linear regression models to the logarithms of the death rates. Age-standardised rates for each individual calendar year were calculated by applying the age-specific rates in each five-year age-group in each calendar year to the European standard population. The Table shows age- and sex-specific, and male-female-combined all-ages, mortality rates per million resident population. The Graph shows agestandardised mortality rates for mortality rates based on underlying cause and for mortality rates based on mentions, for males and females separately. Mortality trends in England; ICD9 (714.0-714.2), ICD10 (M05-M06); File: Sepho 96-04 V2

Some technical notes: Dataset used: UHCE-built multi-year file for England, England_sepho.deaths.reg96-04unf300.v2, using the SEPHO mortality files for individual calendar years supplied by the ONS Deaths were coded to ICD9 714.0-714.2 for the years 1996-2000 and to ICD10 M05-M06 for 2001-2004 Diagnosis position: underlying cause, and all mentions Period covered: deaths by date of occurrence from 1.1.1996 to 31.12.2004. Deaths in the final year for which data are available, namely 2004, may be slightly low due to late registration of some deaths Age/sex restriction: all ages, males and females separately Restrictions in record selection: none Place of residence at time of death: England We are very grateful for computing support from Myfanwy Griffith and Leicester Gill. Work funded by the NHS National Centre for Research Capacity Development. Henry McGuiness and Daniel Meddings are funded by the South East England Public Health Observatory. Ethical approval: REC references 04/Q2006/175 and 04/Q2006/176. Copyright 2006 UHCE, Oxford University Mortality trends in England; ICD9 (714.0-714.2), ICD10 (M05-M06); File: Sepho 96-04 V2

Rheumatoid arthritis in England Number of deaths, age-standardised mortality rates 1996-2004 for underlying cause and for mentions; average annual change in rates for mentions, and 95% confidence intervals on the change in mentions Rates per million Age group n Underlying Mentions Average cause annual 1996-04 1996-04 % change ( 95% CI) Men 0-44 19 0.0 0.1 4.1-9.4 19.5 45-54 138 1.0 4.8-9.3-15.3-3.0 55-64 692 6.9 30.3-5.6-7.6-3.6 65-74 2098 29.9 118.7-4.4-6.0-2.8 75+ 2977 63.3 247.8-3.7-5.0-2.3 all age 5924 5.6 22.3-4.3-4.9-3.8 Women 0-44 80 0.2 0.6-9.2-14.9-3.1 45-54 309 3.7 12.0-8.8-12.4-5.0 55-64 1276 16.1 60.7-5.8-8.5-2.9 65-74 4465 64.6 244.2-5.4-6.9-3.9 75+ 11448 186.2 599.2-4.0-5.3-2.7 all age 17578 14.4 49.8-4.9-6.2-3.6 Total 23502 10.0 36.1-4.7-5.7-3.7 Mortality trends in England; ICD9 (714.0-714.2), ICD10 (M05-M06); File: Sepho 96-04 V2; Created: 16/05/2006

Rheumatoid arthritis in England: age-standardised mortality rates 1996-2004, males 60 Mortality rates per million population 50 40 30 20 10 0 1996 1997 1998 1999 2000 2001 2002 2003 2004 Mentions Underlying cause Year Rheumatoid arthritis in England: age-standardised mortality rates 1996-2004, females 60 Mortality rates per million population 50 40 30 20 10 0 1996 1997 1998 1999 2000 2001 2002 2003 2004 Mentions Underlying cause Year Mortality trends in England; ICD9 (714.0-714.2), ICD10 (M05-M06); File: Sepho 96-04 V2; Created: 16/05/2006

Rheumatoid arthritis in England: age-standardised mortality rates 1996-2004, males and females 60 Mortality rates per million population 50 40 30 20 10 0 1996 1997 1998 1999 2000 2001 2002 2003 2004 Mentions Underlying cause Year Mortality trends in England; ICD9 (714.0-714.2), ICD10 (M05-M06); File: Sepho 96-04 V2; Created: 16/05/2006